Computer-assisted liver surgery: Clinical applications and technological trends

Critical Reviews in Biomedical Engineering

Volumn 40, Issue 3, 2012, Pages 199-220

  Peterhans, Matthias ^a   Oliveira, Thiago ^b   Banz, Vanessa ^b   Candinas, Daniel ^b   Weber, Stefan ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3D VISUALIZATION; ANATOMICAL ORIENTATION; BACKGROUND INFORMATION; BILE DUCTS; BLOOD VESSEL SYSTEMS; CLINICAL APPLICATION; CLINICAL EXPERIENCE; CLINICAL STUDY; CLINICAL TRIAL; COMPUTER AIDED; COMPUTER ASSISTED; COMPUTER SUPPORT; FUNCTIONAL TISSUE; FURTHER DEVELOPMENT; INTERNAL ORGANS; LIVER SURGERY; LIVER TUMORS; NAVIGATION TECHNOLOGY; ORGAN DEFORMATION; ORGAN MOTION; ORGAN REGENERATION; TECHNOLOGICAL TRENDS; TUMOR LOCATION; TUMOR TISSUES;

BLOOD VESSELS; DEFORMATION; MEDICAL COMPUTING; THREE DIMENSIONAL COMPUTER GRAPHICS; TUMORS;

SURGERY;

COLORECTAL CANCER; COMPUTER ASSISTED SURGERY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LAPAROSCOPIC SURGERY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER SURGERY; LIVER TUMOR; METASTASIS; PRIORITY JOURNAL; REVIEW; STEREOTACTIC PROCEDURE; BREATHING; COMPUTER SIMULATION; HISTOLOGY; LIVER; METHODOLOGY; MOTION; THREE DIMENSIONAL IMAGING;

COMPUTER SIMULATION; HUMANS; IMAGING, THREE-DIMENSIONAL; LIVER; LIVER NEOPLASMS; MOTION; RESPIRATION; SURGERY, COMPUTER-ASSISTED;

EID: 84865109360     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v40.i3.40     Document Type: Review

References (66)

1. Lang H, Radtke A, Hindennach M, Schroeder T, Frühauf NR, Malagó M, Bourquain H, Peitgen H-O, Oldhafer KJ, Broelsch CE. Impact of virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg. 2005;140;(7):629-38; discussion 638.
2. Radtke A, Sotiropoulos GC, Molmenti EP, Schroeder T, Peitgen HO, Frilling A, Broering DC, Broelsch CE, Malago M. Computer-assisted surgery planning for complex liver resections: when is it helpful? A single-center experience over an 8-year period. Ann Surg. 2010;252(5) (Nov):876-83.
3. Rieder C, Weihusen A, Schumann C, Zidowitz S, Peitgen H-O. Visual support for interactive post-interventional assessment of radiofrequency ablation therapy. Comput Graphics Forum. 2010;29(3) (June 1):1093-102.
4. Herline AJ, Stefansic JD, Debelak JP, Hartmann SL, Pinson CW, Galloway RL, Chapman WC. Image-guided surgery: preliminary feasibility studies of frameless stereotactic liver surgery. Arch Surg. 1999;134(6): 644-49; discussion 649-50.
5. O A, WHO {pipe} Disease and injury regional estimates for 2004. Available at: http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html [Accessed September 22, 2009].
6. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001. 94(2) (Oct):153-6.
7. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001,48(2):251-9.
8. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L Colombo, M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35(3)(Sept):421-30.
9. Lo C-M, Ngan H, Tso W-K, Liu C-L, Lam C-M, Poon R.T.-P, Fan S-T, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35(5):1164-71.
10. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359(9319) (May 18):1734-9.
11. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51-64.
12. Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. a comparison with resective treatment. Ann Surg. 1984;199(5):502-8.
13. Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Makuuchi M. Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. Surgery. 2001;129 (April):408-13.
14. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg. 1999;86(3):332-7.
15. Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma. a study of 216 autopsy cases. Am J Surg. 1978;135(6):807-10.
16. Hoe AL, Royle GT, Taylor I. Breast liver metastases-incidence, diagnosis and outcome. J R Soc Med. Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, Gamucci T, Minisini A, Therasse P, Piccart MJ. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer. 2003;39(17):2439-49.
17. Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, Calvert AH, et al. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer. 2003;39(17):2439-49.
18. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg. 1994;129(7):712-7.
19. Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF 2nd. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology. 1983;84(5 Pt 1):994-1002.
20. Fasulo, F, A Giori, S Fissi, F Bozzetti, R Doci, and L Gennari. 1992. "Cavitron Ultrasonic Surgical Aspirator (CUSA) in liver resection. " International Surgery 77 (1) (March): 64-66.
21. Koo BN, Kil HK, Choi J-S, Kim JY, Chun DH, Hong YW. Hepatic resection by the Cavitron Ultrasonic Surgical Aspirator increases the incidence and severity of venous air embolism. Anesthes Analges. 2005;101(4)(Oct):966-70, ToC.
22. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien P-A. How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg. 2005;242(6) (Dec):814-22, discussion 822-3.
23. Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection-2,804 patients. Ann Surg. 2009;250(5) (Nov):831-41.
24. Gumbs AA, Bar-Zakai B, Gayet B. Totally laparoscopic extended left hepatectomy. J Gastrointest Surg. 2008;12(7):1152.
25. Ganguli S, Kruska JB, Brennan DD, Kane RA. Intraoperative laparoscopic ultrasound. Radiol Clin N Am. 2006;44(6)(Nov):925-35.
26. Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, Koga M, Yano M. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol. 2000;32(2):269-78.
27. Lin S-M, Lin C-J, Lin C-C, Hsu C-W, Chen Y-C. Randomised controlled trial comparing percutaneous raiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54(8):1151-6.
28. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228(1) (Jul):235-40.
29. Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T, Moschouris H, Emmanouil E, Rizos S, Kelekis D. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2010;33(3) (June):541-51.
30. Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion. 2007;75(2-3):104-12.
31. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K Okita, K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. comparison with standard percutaneous radiofrequency ablation therapy. Cancer. 2002;95(11) (Dec 1):2353-60.
32. Heizmann O, Zidowitz S, Bourquain H, Potthast S, Peitgen H-O, Oertli D, Kettelhack C. Assessment of intraoperative liver deformation during hepatic resection: prospective clinical study. World J Surg. 2010;34(8):1887-93.
33. Dumpuri P, Clements LW, Dawant BM, Miga MI. Model-updated image-guided liver surgery: preliminary results using surface characterization. Prog Biophys Mol Biol. 2010;103(2-3) (Dec):197-207.
34. Peterhans M, Vom Berg A, Dagon B, Inderbitzin D, Baur C, Candinas D, Weber S. A navigation system for open liver surgery: Design, workflow and first clinical applications. Int J Med Robot Comput Assist Surg. 2011;7(1) (March):7-16.
35. Beller S, Hünerbein M, Lange T, Eulenstein S, Gebauer B, Schlag PM. Image-guided surgery of liver metastases by three-dimensional ultrasound-based optoelectronic navigation. Br J Surg. 2007;94(7):866-75.
36. Oldhafer K, Stavrou G, Prause G, Peitgen H-O, T Lueth, Weber S. How to operate a liver tumor you cannot see. Arch Surg. 2009;394(3) (May 1):489-94.
37. Clements L, Dumpuri P, Chapman W, Dawant B, Galloway R, Miga M. Organ surface deformation measurement and analysis in open hepatic surgery: method and preliminary results from 12 clinical cases. IEEE Trans Biomed Eng. Vol. 58, No. 8, August 2011: 2280-2289; http://www.ncbi.nlm.nih.gov/pubmed/21521662
38. Chopra SS, Hünerbein M, Eulenstein S, Lange T, Schlag PM, Beller S. Development and validation of a three dimensional ultrasound based navigation system for tumor resection. Eur J Surg Oncol.;2008 Apr;34(4):456-61.
39. Penney GP, Blackall JM, Hamady MS, Sabharwal T, Adam A, Hawkes DJ. Registration of freehand 3D ultrasound and magnetic resonance liver images. Med Image Anal. 2004;8(1) (March):81-91.
40. Dagon B, Baur C, Bettschart V. Intraoperative update of liver surgery planning based on ultrasound images. Presented at: SURGETICA, Chambéry, France, September 19-21, 2007. Published in: Computer-Aided Medical Interventions: tools and applications, p. 419-423 Sauramps Medical, 2007 Sauramps Medical; 2007. p. 419-23.
41. Lange T, Papenberg N, Heldmann S, Modersitzki J, Fischer B, Lamecker H, Schlag PM. 3D ultrasound-CT registration of the liver using combined landmark-intensity information. Int J Comput Assist Radiol Surg. 2009;4(1):79-88.
42. Hildebrand P, Kleemann M, Schlichting S, Martens V, Besirevic A, Roblick U, Bruch HP, Bürk C. Prototype of an online navigation system for laparoscopic radiofrequency ablation. Hepato-Gastroenterol. 2009;56(96) (Dec):1710-3.
43. Nicolau SA, Pennec X, Soler L, Buy X, Gangi A, Ayache N, Marescaux J. An augmented reality system for liver thermal ablation: design and evaluation on clinical cases. Med Image Anal. 2009;13(3) (June):494-506.
44. Oliveira-Santos T, Peterhans M, Roth B, Thalmann G, Reyes M, Nolte L-P, Weber S. Computer aided surgery for percutaneous nephrolithotomy: clinical requirement analysis and system design. Proceedings of IEEE Engineering in Medicine and Biology Society Conference. Piscataway, NJ: IEEE; 2010. P. 442-5.
45. Maier-Hein L, Tekbas A, Seitel A, Pianka F, Müller SA, Satzl S, Schawo S, Radeleff B, Tetzlaff R, Franz AM, Müller-Stich BP, Wolf I, Kauczor HU, Schmied BM, Meinzer HP. 2008. In-vivo targeting of liver lesions with a navigation system based on fiducial needles. Bildverarbeitung Med; 2008 Dec;35(12):5385-96.
46. Bale R, Widmann G, Stoffner DIR. Stereotaxy: Breaking the limits of current radiofrequency ablation techniques. Eur J Radiol. 2010;75(1):32-6.
47. Widmann G, Schullian P, Haidu M, Wiedermann FJ, Bale R. Respiratory motion control for stereotactic and robotic liver interventions. Int J Med Robot Comput Assist Surg. 2010;6(3) (Sept):343-9.
48. Biro P, Spahn DR, Pfammatter T. High-frequency jet ventilation for minimizing breathing-related liver motion during percutaneous radiofrequency ablation of multiple hepatic tumours. Br J Anaesthesia. 2009;102(5):650-3.
49. Nicolau S, Pennec X, Soler L, Ayache N. Clinical evaluation of a respiratory gated guidance system for liver punctures. Proceedings of Medical Image Computing and Computer-Assisted Intervention. Springer Heidelberg. 2007. p. 77-85.
50. Oliveira-Santos T, Hofmann S, Peterhans M, Weber S. Soft tissue tracking for open liver surgery. CURAC. Der Andere Verlag, Uelvesbüll; 2010. p. 39-43.
51. Maier-Hein L, Müller SA, Pianka F, Wörz S, Müller-Stich BP, Seitel A, Rohr K, Meinzer H-P, Schmied BM, Wolf I. Respiratory motion compensation for CT-guided interventions in the liver. Comput Aided Surg. 2008;13(3):125-38.
52. Lamadé W, Vetter M, Hassenpflug P, Thorn M, Meinzer HP, Herfarth C. Navigation and image-guided HBP surgery: a review and preview. J Hepato-Biliary-Pancreatic Surg. 2002;9(5)(Nov 5):592-9.
53. Vetter M, Wolf P, Hassenpflug, Hastenteufel M, Meinzer HP. Navigation aids and real-time deformation modeling for open liver surgery. Med Imaging. 2003; Proceedings of the SPIE, Volume 5029, pp. 58-68 (2003).
54. Markert M, Koschany A, Lueth T. Tracking of the liver for navigation in open surgery. Int J Comput Assist Radiol Surg. 2010;5(3) (May):229-35.
55. Wein W, Khamene A, Clevert D, Kutter O, Navab N. Simulation and fully automatic multimodal registration of medical ultrasound. Proceedings of Medical Image Computing and Computer-Assisted Intervention, Lecture Notes in Computer Science. Brisbane: Springer; 2007. p. 136-43.
56. Blackall JM, Penney GP, King AP, Hawkes DJ. 2005. Alignment of sparse freehand 3-D ultrasound with preoperative images of the liver using models of respiratory motion and deformation. IEEE Trans Med Imaging. 24(11):1405-16.
57. Beller S, Eulenstein S, Lange T, Hünerbein M, Schlag P. Upgrade of an optical navigation system with a permanent electromagnetic position control. J Hepato-Biliary-Pancreatic Surg. 2009;16(2):165-70.
58. Lange T, Eulenstein S, Kraft S, Schlag PM. Electromagnetic anchor tracking for soft tissue navigation. CURAC. Der Andere Verlag, Uelvesbüll; 2010. p. 211-3.
59. Cash DM, Sinha TK, Chapman WC, Terawaki H, Dawant BM, Galloway RL, Miga MI. Incorporation of a laser range scanner into image-guided liver surgery: surface acquisition, registration, and tracking. Med Phys. 2003;30(7):1671-82.
60. Cash DM, Miga MI, Sinha TK, Galloway RL, Chapman WC. Compensating for intraoperative soft-tissue deformations using incomplete surface data and finite elements. IEEE Trans Med Imaging. 2005;24(11):1479-91.
61. Cash DM, Miga MI, Glasgow SC, Dawant BM, Clements LW, Cao Z, Galloway RL, Chapman WC. Concepts and preliminary data toward the realization of image-guided liver surgery. J Gastrointest Surg. 2007;11(7)(July 26):844-59.
62. Beller S, Hunerbein M, Eulenstein S, Lange T, Schlag P. Feasibility of navigated resection of liver tumors using multiplanar visualization of intraoperative 3-dimensional ultrasound data. Ann Surg. 2007;246(2):288-94.
63. Markert M, Weber S, Lueth TC. Manual registration of ultrasound with CT/planning data for hepatic surgery. Stud Health Technol Informatics. 2007;125:319-21.
64. Vom Berg A, Candinas D, Inderbitzin D, Peterhans M, Weber S, Nolte L-P. Computer assisted surgery and navigation in complex hepatic surgery and tumorablation: first clinical results of 10 patients with primary or secondary liver cancer. Int J Comput Assist Surg Radiol. 2010;5(Suppl 1):117-8.
65. Widmann G, Schullian P, Haidu M, Bale R. Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. Cardiovasc Intervent Radiol. 2011; (June 14): http://www.ncbi.nlm.nih.gov/pubmed/21671150
66. Haidu M. Dobrozemsky G, Schullian P, Widmann G, Klaus A, Weiss H, Margreiter R, Bale R. Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study. Cardiovasc Intervent Radiol 2011;(Oct 18); http://www.ncbi.nlm.nih.gov/pubmed/22006031